Rx Products

NOVEMBER 27, 2017


SOLOSEC
MANUFACTURED BY: Symbiomix Therapeutics
INDICATION: The FDA has approved Solocec (secnidazole)
2 g oral granules to treat bacterial vaginosis in adult women, making it the first single-dose therapy for this condition.
DOSAGE FORM: Oral granules: 2 g
FOR MORE INFORMATION: symbiomix.com


KYMRIAH
MANUFACTURED BY: Novartis
INDICATION: The FDA has approved Kymriah (tisagenlecleucel), the first chimeric antigen receptor T-cell therapy to be available in the United States, to treat patients up to age 25 years with B-cell precursor acute lymphoblastic leukemia that is refractory or in second or later relapse.
DOSAGE FORM: Suspension for intravenous infusion
FOR MORE INFORMATION: novartis.com




TRELEGY ELLIPTA
MANUFACTURED BY: GlaxoSmithKline and Innoviva
INDICATION: The FDA has approved Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol [FF/UMEC/VI]) for long-term, once-daily maintenance treatment of patients with COPD, including chronic bronchitis and/or emphysema, who are on a fixed-dose combination of FF/VI for airflow obstruction and reducing exacerba- tions in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed-dose combination of FF/VI.
DOSAGE FORM: Inhalation Powder: Inhaler containing 2 foil blister strips of powder formulation for oral inhalation. One strip contains fluticasone furoate 100 mcg per blister and the other contains umeclidinium/ vilanterol 62.5 mcg/25 mcg per blister.
FOR MORE INFORMATION: gsk.com




ADZENYS ER
MANUFACTURED BY: Neos Therapeutics
INDICATION: The FDA has approved Adzenys ER (amphetamine extended-release) oral suspension to treat attention-deficit/hyperactivity disorder (ADHD).
DOSAGE FORM: Oral suspension
FOR MORE INFORMATION: neostx.com

 

SHARE THIS SHARE THIS
0
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.